Replies to post #20382 on Mymetics Corp (MYMX)

[Work Harder]

The article Danish rare disease biotech Orphazyme files for a $115 million US IPO originally appeared on IPO investment manager Renaissance Capital's web site renaissancecapital.com.

founded in 2009

https://www.nasdaq.com/articles/danish-rare-disease-biotech-orphazyme-files-for-a-%24115-million-us-ipo-2020-09-04

Whew Cow

https://www.renaissancecapital.com/IPO-Investing/Intl-IPO-ETF